99 related articles for article (PubMed ID: 3479706)
1. [Colorectal neoplasms: preoperative determination of GICA].
Bussone R; Sanlorenzo M; Natta F; Rocca N; Caldarola B
Minerva Chir; 1987 Oct; 42(20):1655-6. PubMed ID: 3479706
[No Abstract] [Full Text] [Related]
2. [Preoperative determination of carcinoembryonic antigen and gastrointestinal antigen in neoplastic colorectal pathology. Case contributions].
Ramella A; Bussone R; Sanlorenzo M; Natta F; Caldarola B; Schirripa C; Giani R; Pecchio F; Rocca N
Minerva Chir; 1987 Jun; 42(12):1037-43. PubMed ID: 3476864
[No Abstract] [Full Text] [Related]
3. [Utility of CA19-9 and CEA as tumor marker in colorectal cancer--comparison between serum level and distribution].
Okuda K; Kodaira S; Watanabe M; Takami H; Teramoto T; Abe O; Iri H; Ino Y; Hirohashi S
Nihon Gan Chiryo Gakkai Shi; 1986 Jun; 21(5):969-77. PubMed ID: 3463631
[No Abstract] [Full Text] [Related]
4. [Correlation between the levels of CA 19-9 and Ca-50 in colorectal cancer].
Lamíquiz Vallejo A; Domínguez Merru-Urrutia MJ; Loizate Totoricagüena A; Cruz Fombellida Cortázar J
Med Clin (Barc); 1988 Jan; 90(1):42. PubMed ID: 3162290
[No Abstract] [Full Text] [Related]
5. The clinical significance of serum CA 19-9 in patients with gastric and colorectal carcinoma and immunohistochemical visualization of CA 19-9 in tumor tissues.
Sekikawa K
Fukushima J Med Sci; 1985 Jun; 31(1):29-42. PubMed ID: 3866740
[No Abstract] [Full Text] [Related]
6. [Preoperative determination of serum immunoglobulins in colorectal cancer: correlation between staging and course of the disease].
Secco GB; Frassetto GL; Venturini M; Santi F; Fardelli R; Terrizzi A
Minerva Dietol Gastroenterol; 1986; 32(2):183-6. PubMed ID: 3736967
[No Abstract] [Full Text] [Related]
7. [Significance of CA19-9 values in the feces of patients with colorectal carcinoma].
Taoka H; Ando Y; Kurumiya T; Ohta M; Sanda T; Shimizu T; Okabayashi Y
Nihon Geka Gakkai Zasshi; 1987 May; 88(5):543-50. PubMed ID: 3474513
[TBL] [Abstract][Full Text] [Related]
8. [Detection of T-antigen in colorectal adenocarcinoma and polyps].
Xu S; Lu Y; Wang Q
Zhonghua Nei Ke Za Zhi; 1995 Oct; 34(10):693-5. PubMed ID: 8731834
[TBL] [Abstract][Full Text] [Related]
9. [Follow-up of colorectal neoplasms: use of TPA].
Citone G; Catani M; Procacciante F; Perri S; Pronio A; Ribotta G
Minerva Chir; 1987 Oct; 42(20):1625-6. PubMed ID: 3683924
[No Abstract] [Full Text] [Related]
10. Carbohydrate antigens and liver metastasis in colorectal cancer.
Hasegawa H; Watanabe M; Arisawa Y; Teramoto T; Kodaira S; Kitajima M
Jpn J Clin Oncol; 1993 Dec; 23(6):336-41. PubMed ID: 7904324
[TBL] [Abstract][Full Text] [Related]
11. [Clinical significance of the determination of serum carbohydrate antigen 19-9 in patients with carcinoma of the stomach and colorectum].
Hamazoe R; Yoshioka H; Furumoto T; Kanayama H; Shimizu N; Maeta M; Koga S
Gan No Rinsho; 1985 Aug; 31(10):1287-92. PubMed ID: 3863968
[TBL] [Abstract][Full Text] [Related]
12. [Importance of CEA determination in colo-rectal neoplasms].
Pezcoller C; Ricchi E; Briccoli A; Saviano MS; Ferrara F; De Palma M; Guernelli N
Minerva Chir; 1984 Feb; 39(3):153-60. PubMed ID: 6728213
[No Abstract] [Full Text] [Related]
13. [In vitro studies of autologous and allogeneic recognition in patients with gastric and colorectal adenocarcinoma].
Machado I; Cabrera L; Anderson C; Meilijson O; Pérez L; Bianco N
G E N; 1985; 39(1):1-19. PubMed ID: 2939005
[No Abstract] [Full Text] [Related]
14. [Preoperative determination of TPA in colorectal neoplasms. Evaluation of a group consisting of 75 patients].
Ramella A; Bussone R; Sanlorenzo M; Natta F; Caldarola B; Schirripa C; Giani R; Pecchio F; Rocca N
Minerva Chir; 1987 Jul; 42(13-14):1181-4. PubMed ID: 3670651
[No Abstract] [Full Text] [Related]
15. Correlation between the results of carcinoembryonal antigen (CEA) test and the clinical stage of colorectal carcinoma.
Molnár L; Rahóty P; Bauer E; Rónay P; Besznyák I; Ottó S
Acta Chir Hung; 1986; 27(1):27-34. PubMed ID: 3716715
[TBL] [Abstract][Full Text] [Related]
16. Increase in both CEA and CA19-9 in sera is an independent prognostic indicator in colorectal carcinoma.
Nozoe T; Rikimaru T; Mori E; Okuyama T; Takahashi I
J Surg Oncol; 2006 Aug; 94(2):132-7. PubMed ID: 16847905
[TBL] [Abstract][Full Text] [Related]
17. Immunodiagnosis of colorectal cancer: clinical evaluation of Tennessee antigen (Tenagen).
Dent OF; Chapuis PH; Payne JE; Meyer J; Sutherland AM; Goulston KJ
J Natl Cancer Inst; 1983 Nov; 71(5):893-6. PubMed ID: 6580489
[TBL] [Abstract][Full Text] [Related]
18. [Large intestinal neoplasms and pericancerous immunocompetent cells].
Du ZY
Zhonghua Yi Xue Za Zhi; 1985 Oct; 65(10):593-6. PubMed ID: 3938672
[No Abstract] [Full Text] [Related]
19. Association of antigen expression and DNA ploidy in human colorectal tumors.
Durrant LG; Robins RA; Armitage NC; Brown A; Baldwin RW; Hardcastle JD
Cancer Res; 1986 Jul; 46(7):3543-9. PubMed ID: 3518917
[TBL] [Abstract][Full Text] [Related]
20. [Histological changes in the colonic and rectal cancer stroma observed in patients following immunopotentiation with thymus extract (TFX)].
Urban A; Turowski G; Cybulski L
Patol Pol; 1977; 28(1):47-59. PubMed ID: 854368
[No Abstract] [Full Text] [Related]
[Next] [New Search]
